Glover Nicholas 4
4 · Sierra Oncology, Inc. · Filed Mar 5, 2019
Insider Transaction Report
Form 4
Glover Nicholas
DirectorCEO and President
Transactions
- Award
Stock Option (right to buy)
2019-03-04+607,500→ 607,500 totalExercise: $1.96Exp: 2029-03-04→ Common Stock (607,500 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the total shares on January 1, 2020, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on January 1, 2023, subject to the reporting person's provision of service to the issuer on each vesting date.